GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Manufacturing - Apparel & Accessories » Dr. Martens PLC (STU:3U2) » Definitions » Research & Development

Dr. Martens (STU:3U2) Research & Development : €0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Dr. Martens Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dr. Martens's Research & Development for the six months ended in Sep. 2023 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was €0 Mil.


Dr. Martens Research & Development Historical Data

The historical data trend for Dr. Martens's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Martens Research & Development Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial - - - - -

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Dr. Martens Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr. Martens  (STU:3U2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Dr. Martens Research & Development Related Terms

Thank you for viewing the detailed overview of Dr. Martens's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Martens (STU:3U2) Business Description

Traded in Other Exchanges
Address
28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.

Dr. Martens (STU:3U2) Headlines

No Headlines